摘要
目的分析2种不同雾化吸入糖皮质激素法对支气管哮喘患者治疗效果。方法 2015年2月—2017年4月,方便选取符合条件的支气管哮喘患者87例,选择持续氧驱动雾化吸入治疗患者42例,纳入A组,选择间歇氧驱动雾化吸入治疗对象45例,纳入B组。对比初次雾化治疗后体征与血氧饱和度指标、预后情况。结果初次治疗吸入1 h后,B组与A组呼吸频率低于吸入前、B组对于A组,2组血氧饱和度高于吸入前、B组高于A组,差异有统计学意义(P<0.05)。A组症状控制时间(15.6±4.6)h,高于对照组(10.6±5.6)h,差异有统计学意义(P<0.05)。2组住院时间、并发症发生率差异无统计学意义(P>0.05)。结论间歇雾化吸入糖皮质激素法治疗支气管哮喘的疗效更好,有助于更好的控制症状,加速患者康复。
Objective This paper tries to analyze two kinds of inhaled corticosteroid in treatment of patients with bronchial asthma. Methods 87 patients with bronchial asthma from February 2015 to April 2017 were convenient selected. 42 patients adopted continuous oxygen atomizing inhalation were selected as group A; 45 cases adopted intermittent oxygen atomizing inhalation were selected as group B. The signs and contrast spray oxygen saturation index, prognosis situations after the first treatment of the two groups were compared. Results After the initial treatment for one hour of inhalation, the inhaled respiratory rate of group B and group A after inhalation was lower than before inhalation; blood oxygen saturation degree of two groups was higher than that of before inhalation, and that of group B was higher than group A, the difference was statistically significant(P〈0.05). The symptom control time in group A was(15.6±4.6) h, higher than that of the control group of(10.6±5.6) h, the difference was statistically significant(P〉0.05). There were no significant differences in the hospitalization time and complications rate of the two groups(P 0.05). Conclusion The curative effect of intermittent inhaled corticosteroid method is better for bronchial asthma, which can better control symptoms and accelerate the rehabilitation of patients.
出处
《中外医疗》
2017年第29期112-114,共3页
China & Foreign Medical Treatment
关键词
支气管哮喘
雾化吸入
糖皮质激素
Bronchial asthma
Nebulizing inhalation
Glucocorticoids